Found 5 matching trials
Developing and Strengthening Cannabis Warnings: Warning Message Testing
NAThe purpose of this activity is to identify promising cannabis warning mess...
Location
University of North Carolina at Chapel Hill
Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis
PHASE3The purpose of this study is to compare two commonly used agents for the tr...
Location
Lakeland Regional Healthcare
Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)
PHASE4Cannabis Hyperemesis Syndrome (CHS) has become a well-documented syndrome s...
Location
Hotel Dieu Hospital
Cannabinoid Hyperemesis Syndrome. Prospective Multicenter Study of Patients Admitted to Adult Emergency Departments in Maine-et-Loire.
N/ACannabinoid hyperemesis syndrome (CHS) is characterized by incoercible abdo...
Location
Angers Centre Hospitalier Universitaire (CHU)
Droperidol on Prevention of Cannabis Hyperemesis Syndrome
PHASE3The purpose of this study is to assess the efficacy of droperidol as a trea...
Location
Mercy Health - Austintown